Back to search

Article

An Open-Label Feasibility Study of Remdesivir in Long COVID: Results from the ERASE LC Trial

2026-07-28

Abstract excerpt

<h4>Objective</h4> Treatment of acute COVID-19 with anti-viral and immunomodulator medications demonstrates a reduced risk of long-term outcomes. To date, remdesivir, an intravenous (IV) antiviral that prevents RNA transcription, has not been evaluated in people with Long COVID (LC). This study assessed the feasibility of a five-day IV remdesivir intervention for individuals with LC. <h4>Methods</h4> Seventy-thr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4fcc6830-a657-56b7-88e0-d5247a71cdcb
DOI
10.64898/2026.07.26.26358852
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An Open-Label Feasibility Study of Remdesivir in Long COVID: Results from the ERASE LC TrialDOI 10.64898/2026.07.26.26358852
Insights from a double-blind, randomized, direct-to-participant intervention trial for Long COVIDSemantic proximity
Long COVID Treatment No Silver Bullets, Only a Few Bronze BBsSemantic proximity
Characterising long term Covid-19: a living systematic reviewSemantic proximity
Evaluation of the effectiveness of remdesivir in severe COVID-19 using observational data from a prospective national cohort studySemantic proximity
Outpatient Treatment of COVID-19 and the Development of Long COVID Over 10 Months: A Multi-Center, Quadruple-Blind, Parallel Group Randomized Phase 3 TrialSemantic proximity
Long COVID and associated outcomes following COVID-19 reinfections: Insights from an International Patient-Led SurveySemantic proximity
STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: a structured protocolSemantic proximity
What interventions or best practice are there to support people with Long COVID, or similar post-viral conditions or conditions characterised by fatigue, to return to normal activities: a rapid reviewSemantic proximity
Forming a Consensus Opinion on Long COVID Support Mechanisms and Interventions Using a Modified Delphi ApproachSemantic proximity
Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: A systematic review and meta-analysisSemantic proximity
Randomized controlled trials do not support efficacy of any of the tested doses of fluvoxamine in prevention of disease progression in adults with incipient non-severe COVID-19 disease: a case-study systematic review and meta-analysisSemantic proximity
Remdesivir and the Liver: A Concise Narrative Review of Remdesivir-Associated Hepatotoxicity in Patients Hospitalized Due to COVID-19Semantic proximity
Select a neighboring publication to make it the new centre.